Skip to main content

Atea Pharmaceuticals, Inc.

AVIR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001593899

No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Atea Pharmaceuticals, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of AVIR: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders104107+3
Shares52.9M52.7M−255.5K (−0.5%)
Value$158.3M$189.7M+$31.4M (+19.8%)

New holders (13)

Institutions that held Atea Pharmaceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to AVIR in Q2 2025
InstitutionSharesValue% of portfolio
XTX Topco Ltd87,124$313.6K0.01%
Simplex Trading, LLC60,584$218.0K0.01%
Walleye Capital LLC57,759$207.9K0.00%
Rangeley Capital, LLC53,000$190.8K0.24%
Alps Advisors Inc46,165$166.2K0.00%
Brevan Howard Capital Management LP36,567$131.6K0.00%
Los Angeles Capital Management LLC34,075$122.7K0.00%
Marshall Wace, LLP24,867$89.5K0.00%
Johnson Investment Counsel Inc15,340$55.2K0.00%
Wolverine Trading, LLC15,729$54.3K0.00%
Prudential Financial Inc10,135$36.5K0.00%
Raymond James Financial Inc400$1.44K0.00%
Rothschild Investment LLC85$3060.00%

Sold out (10)

Institutions that held Atea Pharmaceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of AVIR in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
HighTower Advisors, LLC75,088$224.5K
Corebridge Financial, Inc.37,802$113.0K
Aldebaran Capital, LLC37,500$112.1K
SG Americas Securities, LLC32,520$97.0K
Connor, Clark & Lunn Investment Management Ltd.30,087$90.0K
Citadel Advisors LLC21,992$65.8K
CIBC World Markets Corp17,122$51.2K
Squarepoint Ops LLC15,756$47.1K
California State Teachers Retirement System5,591$16.7K
Coldstream Capital Management Inc3,188$9.53K